Lysophosphatidylcholine inhibits lung cancer cell proliferation by regulating fatty acid metabolism enzyme long‐chain acyl‐coenzyme A synthase 5

Lung cancer is a widespread malignancy with a high death rate and disorder of lipid metabolism. Lysophosphatidylcholine (lysoPC) has anti‐tumour effects, although the underlying mechanism is not entirely known. The purpose of this study aims at defining changes in lysoPC in lung cancer patients, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Linlin, Liu, Xuanqi, Liu, Yifei, Yan, Furong, Zeng, Yiming, Song, Yuanlin, Fang, Hao, Song, Dongli, Wang, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839868/
https://www.ncbi.nlm.nih.gov/pubmed/36639836
http://dx.doi.org/10.1002/ctm2.1180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839868/
https://www.ncbi.nlm.nih.gov/pubmed/36639836
http://dx.doi.org/10.1002/ctm2.1180

Ejemplares similares